Personal information

Verified email domains

Activities

Employment (3)

Inselspital Universitätsspital Bern: Bern, BE, CH

2019-02 to present | Deputy Head Stroke Centre, Attending physician (Department of Neurology and Stroke Center)
Employment
Source: Self-asserted source
David Seiffge

UCL Institute of Neurology, University College London: London, GB

2017-10-01 to 2019-01-31 | Honorary Research Associate (Brain Repair and Rehabilitation)
Employment
Source: Self-asserted source
David Seiffge

Universtiy Hospital Basel: Basel, CH

2011-06-01 to 2017-09-30 | Resident/Attending Physician (Neurology and Stroke Center)
Employment
Source: Self-asserted source
David Seiffge

Education and qualifications (1)

University of Heidelberg: Heidelberg, DE

2003-09 to 2010-12 | MD (Medical School)
Education
Source: Self-asserted source
David Seiffge

Funding (6)

Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants: The DOAC – International Thrombolysis (DO-IT) randomized controlled trial

2024-10-01 to 2028-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 10003515
Source: Self-asserted source
David Seiffge via DimensionsWizard

Optimal TreaTment of Atrial fibrillation patients With and cardioembolic ischemic stroke despite Anticoagulant therapy - OTTAWA

2024-05-01 to 2029-04-30 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 213615
Source: Self-asserted source
David Seiffge via DimensionsWizard

ELAN benefit, a nested project within the Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN) trial

2021-04-01 to 2025-03-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 197009
Source: Self-asserted source
David Seiffge via DimensionsWizard

Towards understanding mechanism and outcome of intracerebral haemorrhage in patients taking oral anticoagulants - insights from neuroimaging and genetics

Treatment of intracerebral hemorrhage in patientes on non-vitamin K antagonist oral anticoagulants with tranexamic acid (TICH-NOAC)

2016-10-01 to 2021-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 163378
Source: Self-asserted source
David Seiffge via DimensionsWizard

A novel risk index combining degree of stenosis and plaque morphology of the carotid artery: a multicentiric study on a symptomatic 50%-80% or symptomatic 50%-69% carotid stenoses

2008-04-01 to 2014-03-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 116215
Source: Self-asserted source
David Seiffge via DimensionsWizard

Peer review (30 reviews for 14 publications/grants)

Review activity for BMJ neurology open. (4)
Review activity for BMJ open. (6)
Review activity for EClinicalMedicine. (2)
Review activity for European heart journal. (1)
Review activity for Evidence-based medicine (1)
Review activity for Journal of neurointerventional surgery. (1)
Review activity for Journal of neurology. (1)
Review activity for Klinische Neuroradiologie. (1)
Review activity for Open heart. (3)
Review activity for PloS one. (1)
Review activity for Stroke and vascular neurology. (2)
Review activity for The Lancet neurology. (2)
Review activity for The Lancet regional health. (4)
Review activity for The lancet. (1)